Eversept Partners LP lowered its position in Horizon Therapeutics Public Limited (NASDAQ:HZNP – Get Rating) by 16.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,064,446 shares of the biopharmaceutical company’s stock after selling 205,145 shares during […]
Paulson & CO. Inc. trimmed its stake in shares of Horizon Therapeutics Public Limited (NASDAQ:HZNP – Get Rating) by 75.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,500,000 shares of the biopharmaceutical company’s stock after selling 4,600,000 shares […]
Paulson & CO. Inc. reduced its stake in shares of Horizon Therapeutics Public Limited (NASDAQ:HZNP – Get Rating) by 75.4% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 1,500,000 shares of the biopharmaceutical company’s stock after selling 4,600,000 shares during the […]
Vazirani Asset Management LLC bought a new stake in Horizon Therapeutics Public Limited (NASDAQ:HZNP – Get Rating) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 37,749 shares of the biopharmaceutical company’s stock, valued at approximately $4,296,000. Horizon Therapeutics Public comprises 7.3% of Vazirani Asset […]
Deutsche Bank AG grew its stake in Horizon Therapeutics Public Limited (NASDAQ:HZNP – Get Rating) by 6.3% during the 4th quarter, HoldingsChannel reports. The firm owned 2,061,143 shares of the biopharmaceutical company’s stock after buying an additional 122,268 shares during the quarter. Deutsche Bank AG’s holdings in Horizon Therapeutics Public were worth $234,558,000 as of […]